Cargando…

Respiratory Syncytial Virus Infection in High-Risk Infants

Detalles Bibliográficos
Autor principal:	Resch, Bernhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Open 2011
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258584/ https://www.ncbi.nlm.nih.gov/pubmed/22262984 http://dx.doi.org/10.2174/1874285801105010127

Ejemplares similares

Respiratory Syncytial Virus Infection in High-risk Infants – an Update on Palivizumab Prophylaxis
por: Resch, Bernhard
Publicado: (2014)

Epidemiology of Respiratory Syncytial Virus Infection in Preterm Infants
por: Resch, Bernhard, et al.
Publicado: (2011)

Risk Factors for Severe Respiratory Syncytial Virus Lower Respiratory Tract Infection
por: Sommer, Constanze, et al.
Publicado: (2011)

Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection
por: Resch, Bernhard
Publicado: (2017)

Nirsevimab brings breakthrough in the prevention of respiratory syncytial virus infection in infants – Importance of design
por: Zhaori, Getu
Publicado: (2023)

The Changing Landscape of Respiratory Syncytial Virus Infections
por: Bem, Reinout A., et al.
Publicado: (2023)

Is IL-1β a Target for Reducing Hospitalization of Infants Infected with Respiratory Syncytial Virus?
por: Mebratu, Yohannes A., et al.
Publicado: (2021)

Utilization Management Opportunities for Palivizumab for Prophylaxis of Respiratory Syncytial Virus Complications in Infants
por: Curtiss, Frederic R., et al.
Publicado: (2010)

An update on respiratory syncytial virus
por: Piralla, Antonio, et al.
Publicado: (2023)

Respiratory syncytial virus infection in infants in rural Nepal
por: Chu, Helen Y., et al.
Publicado: (2016)

Respiratory Syncytial Virus Resurgence in Italy: The Need to Protect All Neonates and Young Infants
por: Bozzola, Elena
Publicado: (2021)

Pathobiology of Respiratory Syncytial Virus (RSV)
por: Tripp, Ralph A., et al.
Publicado: (2020)

Respiratory Syncytial Virus (RSV) Update
por: Krilov, Leonard R., et al.
Publicado: (2022)

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
por: Mejías, Asunción, et al.
Publicado: (2008)

Respiratory Syncytial Virus Infections in Infants Affected by Primary Immunodeficiency
por: Lanari, Marcello, et al.
Publicado: (2014)

Transient Neutropenia in Immunocompetent Infants with Respiratory Syncytial Virus Infection
por: Korematsu, Tatsuya, et al.
Publicado: (2021)

Respiratory syncytial virus infection in COVID-19 times: Trick or threat?
por: Menasalvas Ruiz, Ana Isabel
Publicado: (2023)

Respiratory syncytial virus infection in COVID-19 times: Trick or threat?
por: Menasalvas Ruiz, Ana Isabel
Publicado: (2023)

The Respiratory Mucosa: Front and Center in Respiratory Syncytial Virus Disease
por: Thwaites, Ryan S., et al.
Publicado: (2019)

Pranlukast treatment and the use of respiratory support in infants with respiratory syncytial virus infection
por: Kubota, Jun, et al.
Publicado: (2022)

The disease burden of respiratory syncytial virus in Infants
por: Munro, Alasdair P.S., et al.
Publicado: (2023)

The epidemiology and risk factors of respiratory syncytial virus and its impact on the timing of immunoprophylaxis
por: Jeena, Prakash Mohan
Publicado: (2018)

Altered cardiac rhythm in infants with bronchiolitis and respiratory syncytial virus infection
por: Esposito, Susanna, et al.
Publicado: (2010)

Use of permissive hypercapnia in the ventilation of infants with respiratory syncytial virus infection
por: Tibby, S. M., et al.
Publicado: (1999)

Fail-Fast in Respiratory Syncytial Virus Vaccine Development
por: Besteman, Sjanna B., et al.
Publicado: (2019)

RESPIRATORY SYNCYTIAL AND OTHER VIRUSES ASSOCIATED WITH RESPIRATORY DISEASE IN INFANTS
por: Jacobs, J.W., et al.
Publicado: (1971)

Detection of respiratory syncytial virus and rhinovirus in healthy infants
por: Hasegawa, Kohei, et al.
Publicado: (2015)

Immunoprophylaxis against respiratory syncytial virus with palvizumab: what is new?
por: Sáfadi, Marco Aurélio P.
Publicado: (2014)

[Translated article] Where does Respiratory Syncytial Virus Hide?
por: Martinón-Torres, Federico, et al.
Publicado: (2022)

Respiratory syncytial virus infection in infants and correlation with meteorological factors and air pollutants
por: Vandini, Silvia, et al.
Publicado: (2013)

Transcriptome assists prognosis of disease severity in respiratory syncytial virus infected infants
por: Jong, Victor L., et al.
Publicado: (2016)

A model of respiratory syncytial virus (RSV) infection of infants in newborn lambs
por: Sitthicharoenchai, Panchan, et al.
Publicado: (2020)

Human respiratory syncytial virus and other viral infections in infants receiving palivizumab
por: Boivin, Guy, et al.
Publicado: (2008)

Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants
por: Simões, Eric A F, et al.
Publicado: (2020)

Infant respiratory syncytial virus infection and childhood asthma: A shift in the paradigm?
por: Rosas‐Salazar, Christian, et al.
Publicado: (2023)

Respiratory syncytial virus associated hospitalizations in preterm infants of 29 to 32 weeks gestational age using a risk score tool for palivizumab prophylaxis
por: Resch, B., et al.
Publicado: (2017)

Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infants
por: Blanken, Maarten O., et al.
Publicado: (2018)

Risk Factors for Respiratory Syncytial Virus–Associated Community Deaths in Zambian Infants
por: Murphy, Caitriona, et al.
Publicado: (2021)

Respiratory syncytial virus in severe lower respiratory infections in previously healthy young Ethiopian infants
por: Weldetsadik, Abate Yeshidinber, et al.
Publicado: (2021)

Effectiveness of palivizumab in preventing respiratory syncytial virus infection in high-risk children
por: Viguria, Natividad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5fp9cd3gp075kudvolfa2i817q